ES2127758T3 - Nuevos inhibidores de la alfa-manosidasa. - Google Patents

Nuevos inhibidores de la alfa-manosidasa.

Info

Publication number
ES2127758T3
ES2127758T3 ES92918131T ES92918131T ES2127758T3 ES 2127758 T3 ES2127758 T3 ES 2127758T3 ES 92918131 T ES92918131 T ES 92918131T ES 92918131 T ES92918131 T ES 92918131T ES 2127758 T3 ES2127758 T3 ES 2127758T3
Authority
ES
Spain
Prior art keywords
alpha
manosidase
beta
new inhibitors
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92918131T
Other languages
English (en)
Inventor
Robert A Farr
Mohinder S Kang
Norton P Peet
Sai P Sunkara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2127758T3 publication Critical patent/ES2127758T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)

Abstract

LOS [4S-(4ALFA, 4ALFA-BETA, 6ALFA, 7ALFA, 7A-ALFA)]-OCTAHIDRO-1H-1PIRINDINA-4,5,6,7-TETROLES Y LOS [4R-(4ALFA, 4A-ALFA, 5ALFA, 6-BETA 7BETA, 7A-BETA)]-OCTAHIDRO-1H-1-PIRINDINA-4,5,6,7-TETROLES SON UTILES COMO INHIBIDORES DE ALFA-MANOSIDASA Y SON UTILES INMUNOESTIMULANTES, AGENTES QUIMIPROTECTORES Y RADIOPROTECTORES, Y AGENTES ANTIMETASTATICOS.
ES92918131T 1991-09-18 1992-08-10 Nuevos inhibidores de la alfa-manosidasa. Expired - Lifetime ES2127758T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76157991A 1991-09-18 1991-09-18
US07/893,171 US5262425A (en) 1991-09-18 1992-06-03 α-mannosidase inhibitors

Publications (1)

Publication Number Publication Date
ES2127758T3 true ES2127758T3 (es) 1999-05-01

Family

ID=27117010

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92918131T Expired - Lifetime ES2127758T3 (es) 1991-09-18 1992-08-10 Nuevos inhibidores de la alfa-manosidasa.

Country Status (15)

Country Link
US (1) US5262425A (es)
EP (1) EP0641327B1 (es)
JP (1) JP3226173B2 (es)
KR (1) KR100244012B1 (es)
AT (1) ATE175960T1 (es)
AU (1) AU659486B2 (es)
CA (1) CA2116224C (es)
DE (1) DE69228259T2 (es)
DK (1) DK0641327T3 (es)
ES (1) ES2127758T3 (es)
FI (1) FI105270B (es)
GR (1) GR3029745T3 (es)
HU (1) HU216789B (es)
NO (1) NO300372B1 (es)
WO (1) WO1993005781A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
AU736668B2 (en) * 1996-10-01 2001-08-02 Glycodesign Inc. Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
US6245316B1 (en) 1997-10-08 2001-06-12 David Platt Enhancement of delivery of radioimaging and radioprotective agents
EP1023290A1 (en) * 1997-10-24 2000-08-02 Glycodesign Inc. Synthesis of swainsonine salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031102A (en) * 1972-10-21 1977-06-21 John Wyeth & Brother Limited Cyclopenteno[b]pyridine derivatives
GB2088860B (en) * 1980-12-09 1984-05-23 Wyeth John & Brother Ltd Process for preparing ring-fused pyridine derivatives

Also Published As

Publication number Publication date
JPH06510785A (ja) 1994-12-01
EP0641327A1 (en) 1995-03-08
FI105270B (fi) 2000-07-14
EP0641327B1 (en) 1999-01-20
DE69228259T2 (de) 1999-06-02
HU216789B (hu) 1999-08-30
AU659486B2 (en) 1995-05-18
ATE175960T1 (de) 1999-02-15
FI941259A0 (fi) 1994-03-17
DK0641327T3 (da) 1999-09-13
JP3226173B2 (ja) 2001-11-05
CA2116224A1 (en) 1993-04-01
NO300372B1 (no) 1997-05-20
NO940972D0 (no) 1994-03-17
GR3029745T3 (en) 1999-06-30
HUT70527A (en) 1995-10-30
US5262425A (en) 1993-11-16
EP0641327A4 (en) 1994-06-01
FI941259A (fi) 1994-03-17
NO940972L (no) 1994-03-17
HU9400787D0 (en) 1994-06-28
DE69228259D1 (de) 1999-03-04
KR100244012B1 (ko) 2000-03-02
AU2477192A (en) 1993-04-27
WO1993005781A1 (en) 1993-04-01
CA2116224C (en) 2003-06-03

Similar Documents

Publication Publication Date Title
NO944430L (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
ES2145915T3 (es) Derivados estereoquimicos de la wortmannina.
ES2148229T3 (es) Eteres y tioeteres en la posicion 17 de 4-aza-esteroides.
DK0386997T3 (da) Anvendelse af 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater i behandlingen af psykose, inflammation og som immunosuppressive midler
DK0563345T3 (da) Nye 4-arylpiperaziner og 4-arylpiperidiner
CO4290353A1 (es) Agonistas de estrogeno
IT8922486A0 (it) Processo per la preparazione di 4-0-fosfati di dopamina o suoi derivati
ES2127758T3 (es) Nuevos inhibidores de la alfa-manosidasa.
FI905419A0 (fi) Icke-joniska roentgenkontrastmedel med hoeg jodhalt.
SE9600120D0 (sv) Novel medical use
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
ITVR910067A1 (it) Fissatore esterno assiale per la composizione di fratture ossee
ES2034678T3 (es) Procedimiento para aumentar la productividad de los cerdos.
PA7801701A1 (es) Compuestos ariltios
HU911196D0 (en) Alpha-mannosidaze and functosidaze inhibitors
PT98268A (pt) Processo para a preparacao de indano-pirrolidino-carbamatos
ES2003063A4 (es) Derivados de pirrolidin-2-ona, que tengan actividad nootropica.
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
PT94011A (pt) Processo para a preparacao de 8 alfa- acilamino-ergolinas e de composicoes farmaceuticas que as contem
IT9019303A0 (it) Nuovo composto antibiotico,jantinomicina e procedimento per prepararlo
ES2072072T3 (es) Utilizacion de la carboximetoxi-2-pirrolina-1.
ITRM940151A0 (it) Impiego di esteruretani per la riconcia.
IT9020228A0 (it) Apparato per trattamenti igienicizzanti di foraggi o simili
FI922016A0 (fi) Foerfarande foer framstaellning av dubbelskyddade 1-karba(1-detia)-3-kefem-4-karboxylsyror.
IT222255Z2 (it) Vestito sterile per intensificatore di brillanza

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 641327

Country of ref document: ES